Mechanistically, it has been shown that mesenchymal stem cell (MSC)-derived CXCL16 promotes the progression of GC cells by inducing the expression of ROR1through the STAT3-mediated pathway (Ikeda et al., 2020). This evidence concerns the gene STAT3 and gastric cancer.